| Miss Stephanie Mae Johnson, LCSW | |
|
25 Jefferson Way, Ste 102, Ketchikan, AK 99901 | |
| (907) 247-7827 | |
| (973) 215-2052 |
| Full Name | Miss Stephanie Mae Johnson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 25 Jefferson Way, Ketchikan, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750521449 | NPI | - | NPPES |
| 1579599 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Stephanie Mae Johnson, LCSW 25 Jefferson Way, Ste 102, Ketchikan, AK 99901 Ph: (907) 247-7827 | Miss Stephanie Mae Johnson, LCSW 25 Jefferson Way, Ste 102, Ketchikan, AK 99901 Ph: (907) 247-7827 |
News Archive
Dennis Paul, PhD, Associate Professor of Pharmacology, and Harry Gould, MD, PhD, the Tom Benson Professor of Neurology at LSU Health Sciences Center New Orleans, have been awarded one of two scientific research grants made in 2009 by The Neuropathy Association. The $80,000 grant will fund research to learn how to prevent nerve cell death in people with uncontrolled or untreated diabetes resulting in neuropathy.
Treatment with the antiplatelet agent prasugrel does not significantly reduce the rate of pain crises or severe lung complications in children with sickle cell disease, according to a report published in the New England Journal of Medicine describing one of the largest and most geographically diverse international clinical trials on sickle cell disease to date.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Standard Review designation to the New Drug Application (NDA) for carfilzomib for the potential treatment of patients with relapsed and refractory multiple myeloma.
As President Barack Obama prepares to give his State of the Union address this evening, new polls show public support for congressional health bills is low, with a majority wanting more focus on the economy instead.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
› Verified 6 days ago
Jasmine F. Stewart, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Suite 403, Ketchikan, AK 99901 Phone: 907-228-4902 Fax: 907-228-5256 | |
John Steven Dempsey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 721 Stedman St, Ketchikan, AK 99901 Phone: 907-225-7825 Fax: 907-225-1541 | |
Frank Joseph Bayles, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 603 Deermount St, Ketchikan, AK 99901 Phone: 802-258-1451 | |
William S. Hardy, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Suite 403, Ketchikan, AK 99901 Phone: 907-228-4902 Fax: 907-228-5256 | |
Patti Green, BSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 Fax: 907-228-5256 | |
Thomas Peter Ryan, LCSW, MAC, CDCII Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 320 Bawden St. #318, Ketchikan, AK 99901 Phone: 907-225-2230 Fax: 907-225-2230 | |
Ms. Donna Jean Scarborough, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3050 5th Ave, Ketchikan, AK 99901 Phone: 907-228-6509 Fax: 907-247-4135 |